Last $37.98 USD
Change Today +0.58 / 1.55%
Volume 454.4K
As of 8:10 PM 01/28/15 All times are local (Market data is delayed by at least 15 minutes).

natus medical inc (BABY) Snapshot

Previous Close
Day High
Day Low
52 Week High
01/13/15 - $39.12
52 Week Low
04/15/14 - $21.54
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for NATUS MEDICAL INC (BABY)

Related News

No related news articles were found.

natus medical inc (BABY) Related Businessweek News

No Related Businessweek News Found

natus medical inc (BABY) Details

Natus Medical Incorporated provides newborn care and neurology healthcare products worldwide. It offers healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders. The company’s product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; newborn care products, such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, and incubators to control the newborn’s environment; and software systems for managing and tracking disorders and diseases for public health laboratories. It provides ALGO, ABaer, AuDX, and Echo-Screen newborn hearing screeners; and hearing screening supply products that are used with newborn hearing screening devices. The company also offers diagnostic hearing assessment product lines, which include the Navigator Pro system, the Scout sport portable diagnostic device, and the AuDX PRO; and diagnostic hearing supply products. In addition, it provides monitoring systems, balance and mobility products, newborn brain injury diagnostic products, thermoregulation products, and jaundice management products. Further, the company offers photometers, radiometers, patient warming lamps, neonatal heatshields, pediatric scales, blanket warming cabinets, exam lights, oxygen hoods, restraining boards, and newborn circumstraint; neonatal noise attenuators, phototherapy eye masks, and x-ray shields for reproductive organs; and newborn screening data management products. It serves hospitals, clinics, laboratories, physicians, nurses, audiologists, and governmental agencies. Natus Medical Incorporated was founded in 1987 and is headquartered in San Carlos, California.

943 Employees
Last Reported Date: 03/17/14
Founded in 1987

natus medical inc (BABY) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $500.0K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $350.0K
Vice President and General Manager of Newborn...
Total Annual Compensation: $302.9K
Vice President and General Manager of Neurolo...
Total Annual Compensation: $265.0K
Vice President of Medical Affairs, Quality & ...
Total Annual Compensation: $257.0K
Compensation as of Fiscal Year 2013.

natus medical inc (BABY) Key Developments

Natus Medical Inc., Q4 2014 Earnings Call, Jan 28, 2015

Natus Medical Inc., Q4 2014 Earnings Call, Jan 28, 2015

Natus Medical Inc. to Report Q4, 2014 Results on Jan 28, 2015

Natus Medical Inc. announced that they will report Q4, 2014 results at 9:00 AM, Eastern Standard Time on Jan 28, 2015

Natus Medical Incorporated Provides Revenue Guidance for the Fourth Quarter of 2014 and Provides Earnings Guidance for the First Quarter and Full Year of 2015

Natus Medical Incorporated announced revenue guidance for the fourth quarter of 2014 and provided earnings guidance for the first quarter and full year of 2015. The company expects to report revenue of approximately $94.0 million for the fourth quarter of 2014, achieving the high end of the company's prior guidance for the fourth quarter of $92 to $94 million. For the full year 2015, the company expects to report revenue of $367 million to $369 million and non-GAAP earnings per share of $1.40 to $1.44. For the first quarter of 2015, the company expects to report revenue of $87 million to $89 million and non-GAAP earnings per share of $0.28 to $0.30, an increase of 8% to 15% over the first quarter of 2014 non-GAAP earnings per share of $0.26. The company's non-GAAP earnings per share guidance excludes charges for amortization expense associated with intangible assets from prior acquisitions, which the company expects to be approximately $6.4 million and $1.6 million for the full year and first quarter 2015, respectively, and which the company expects will reduce GAAP earnings per share by approximately $0.20 and $0.05 for the respective periods.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BABY:US $37.98 USD +0.58

BABY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CareFusion Corp $59.56 USD -0.18
NeuroMetrix Inc $1.72 USD -0.0248
NuVasive Inc $46.47 USD -0.46
Oxford Instruments PLC 781.50 GBp +1.50
View Industry Companies

Industry Analysis


Industry Average

Valuation BABY Industry Range
Price/Earnings 39.0x
Price/Sales 3.4x
Price/Book 3.6x
Price/Cash Flow 39.4x
TEV/Sales 3.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NATUS MEDICAL INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at